Skip to main content

Targeted Grand Challenges: A Turning Point for the National Nanotechnology Initiative

Expert Reviews
The conclusions and recommendations by the Presidential Council of Advisors on Science & Technology (PCAST) in the fifth assessment of the National Nanotechnology Initiative (NNI) has determined that a turning point has been reached. In a future vision wherein the ability to understand and control matter at the nanoscale enables a revolution in technology providing significant societal and economic benefit, the Federal Government must transition its activities toward facilitating commercialization.


NanoInformatics 2015: Enabling successful discovery and applications

The Nanoinformatics 2015 workshop will bring together stakeholders in order to assess the state of informatics relevant to the all aspects of the nanotechnology enterprise and to set priority targets for the future formation of a community of practice rather than an aggregation of individual research interests. From materials to processes to products; accessible data, information, models, and simulations will enable innovators to optimize performance and accelerate the innovation cycle from concept to product. Scientists and engineers will be able to efficiently assess the safety of new nanomaterials and quantitatively implement best practices of safe manufacturing and usage of nanomaterials throughout product lifecycles.


New nanodevice to improve cancer treatment monitoring

Press Releases
In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led by Jean-François Masson and Joelle Pelletier of the university's Department of Chemistry.
Methotrexate has been used for many years to treat certain cancers, among other diseases, because of its ability to block the enzyme dihydrofolate reductase (DHFR).


Graphene Frontiers Secures Patent for Commercial-Scale Material Production

Press Releases
Graphene Frontiers LLC, a prominent developer of graphene materials and device technology, announces the issuance of a key industry patent. U.S. Patent 8,822,308, titled “Methods and Apparatus for Transfer of Films among Substrates,” covers the transfer of graphene films between surfaces using roll-to-roll manufacturing processes.
“We were aggressively pursuing this patent and securing it is a testament to the hard work and resiliency of the entire team,” Graphene Frontiers’ CEO Mike Patterson said.
This was the final hurdle in creating a cost-effective production process for graphene.


User Facilities


NanoBCA DC Roundtable 2014

What is Nanomanufacturing?

Nanomanufacturing is the essential bridge between the discoveries of the nano sciences and real-world nanotechnology-enabled products.